Finance Home - My Yahoo - Yahoo! - Help

Monday, November 9, 2009, 8:11PM ET - U.S. Markets Closed. Dow  2.03% Nasdaq  1.97%

Nymox Pharmaceutical Corporation (NYMX)

At 3:59PM ET: 4.97   0.14 (2.74%)

MORE ON NYMX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Oct 14, 2009 • Nymox's NX-1207 to be Clinically Tested for Prostate Cancer GlobeNewswire (Wed, Oct 14) Mon, Oct 5, 2009 • Nymox Announces New Pooled Analysis Confirms 12 Month Benefit of NX-1207 Treatment for BPH GlobeNewswire (Mon, Oct 5) Wed, Aug 26, 2009 • [$$] Stocks in the Spotlight Wednesday at Barrons.com (Wed, Aug 26) • Vonage Up on Google Voice News SmallCapInvestor.com (Wed, Aug 26) • Nymox to advance drug program, shares surge AP (Wed, Aug 26) • Nymox's NX-1207 Shows Major Effect On Liver Cancer GlobeNewswire (Wed, Aug 26) Fri, Aug 14, 2009 • Nymox Pharma 2Q loss widens on higher costs AP (Fri, Aug 14) • Nymox Reports Second Quarter 2009 Financial Results GlobeNewswire (Fri, Aug 14) Wed, Jun 24, 2009 • 9 Stocks to Shake the Market at Motley Fool (Wed, Jun 24) Tue, Jun 2, 2009 • Nymox Announces Dosing of First Patient in Phase 3 Trial for NX-1207 for BPH GlobeNewswire (Tue, Jun 2) Fri, May 15, 2009 • Nymox Reports First Quarter 2009 Financial Results GlobeNewswire (Fri, May 15) Tue, May 5, 2009 • Nymox Announces Start of Second Phase 3 Trial for NX-1207 for BPH GlobeNewswire (Tue, May 5) Tue, Apr 21, 2009 • Nymox Reports Initiation of Phase 3 Trials for NX-1207 for BPH GlobeNewswire (Tue, Apr 21) Fri, Mar 20, 2009 • NYMOX PHARMACEUTICAL CORP Financials EDGAR Online Financials (Fri, Mar 20) Fri, Mar 13, 2009 • Nymox Reports 2008 Financial Results GlobeNewswire (Fri, Mar 13) Tue, Feb 24, 2009 • Nymox Announces New Positive Results At 5 Years After Single Treatment in Long Term Study of NX-1207 for Benign Prostatic Hyperplasia GlobeNewswire (Tue, Feb 24) Wed, Feb 18, 2009 • Nymox Provides Update On Pivotal Phase 3 Trials for BPH Drug GlobeNewswire (Wed, Feb 18) Tue, Jan 13, 2009 • Nymox Releases Positive New Clinical Trial Data On Durability of Response Rates to Company's BPH Drug NX-1207 GlobeNewswire (Tue, Jan 13) Thu, Jan 8, 2009 • Third Hand Smoke Recognized as Health Hazard GlobeNewswire (Thu, Jan 8) Tue, Dec 30, 2008 • Nymox Announces $15 Million Equity Financing Commitment GlobeNewswire (Tue, Dec 30) Older Headlines - Download Recent Headlines View headlines from: Tue, Dec 30, 2008Tue, Dec 23, 2008Tue, Dec 16, 2008Tue, Dec 9, 2008Tue, Dec 2, 2008Tue, Nov 25, 2008Tue, Nov 18, 2008Tue, Nov 11, 2008Tue, Nov 4, 2008Tue, Oct 28, 2008 Add NYMX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage